|
|
|
By Guillermo “Gil” Marmol, Porosome Therapeutics, Inc. | About 85% of disease-causing proteins remain impervious to current therapeutic interventions. One potential pathway to address this problem: the porosome. |
|
|
Pacesetters Are Product Innovators Who Embrace Digital Process Enhancement | A conversation with Jordan Schmitting, senior research analyst, The Josh Bersin Company | The Josh Bersin Company recently underwent research examining pharma/biotech “pacesetters” in the field. We caught up with Jordan Schmitting, senior research analyst at The Josh Bersin Company, to discuss the trends illuminated by the research. |
|
|
|
|
| Empowering A New Era Of Patient-Centric Medicines | Podcast | Nanoform | Discover the challenges pharma companies are facing as they switch focus as well as the actions and technologies companies are implementing to help achieve a brighter future for patients. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|